The synergy of artificial intelligence and personalized medicine for the enhanced diagnosis, treatment, and prevention of disease-Reference-Cited by-同舟云学术

The synergy of artificial intelligence and personalized medicine for the enhanced diagnosis, treatment, and prevention of disease

Published:2024-06-01 Issue:2 Volume:39 Page:47-58
ISSN:2363-8915
Container-title:Drug Metabolism and Personalized Therapy
language:en
Short-container-title:

Author:

Zahra Mohammad Abu¹,Al-Taher Abdulla¹,Alquhaidan Mohamed¹,Hussain Tarique²,Ismail Izzeldin¹,Raya Indah³,Kandeel Mahmoud¹⁴

Affiliation:

1. Department of Biomolecular Sciences, College of Veterinary Medicine , 114800 King Faisal University , Al-Hofuf , Al-Ahsa , Saudi Arabia

2. Animal Sciences Division , Nuclear Institute for Agriculture and Biology (NIAB) , Faisalabad , Pakistan

3. Department of Chemistry, Faculty of Mathematics, and Natural Science , Hasanuddin University , Makassar , Indonesia

4. Department of Pharmacology, Faculty of Veterinary Medicine , Kafrelshikh University , Kafrelshikh , Egypt

Abstract

Abstract Introduction The completion of the Human Genome Project in 2003 marked the beginning of a transformative era in medicine. This milestone laid the foundation for personalized medicine, an innovative approach that customizes healthcare treatments. Content Central to the advancement of personalized medicine is the understanding of genetic variations and their impact on drug responses. The integration of artificial intelligence (AI) into drug response trials has been pivotal in this domain. These technologies excel in handling large-scale genomic datasets and patient histories, significantly improving diagnostic accuracy, disease prediction and drug discovery. They are particularly effective in addressing complex diseases such as cancer and genetic disorders. Furthermore, the advent of wearable technology, when combined with AI, propels personalized medicine forward by offering real-time health monitoring, which is crucial for early disease detection and management. Summary The integration of AI into personalized medicine represents a significant advancement in healthcare, promising more accurate diagnoses, effective treatment plans and innovative drug discoveries. Outlook As technology continues to evolve, the role of AI in enhancing personalized medicine and transforming the healthcare landscape is expected to grow exponentially. This synergy between AI and healthcare holds great promise for the future, potentially revolutionizing the way healthcare is delivered and experienced.

Funder

The Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/dmpt-2024-0003/pdf

Reference82 articles.

1. Freimer, N, Sabatti, C. The human phenome project. Nat Genet 2003;34:15–21. https://doi.org/10.1038/ng0503-15.

2. Brittain, HK, Scott, R, Thomas, E. The rise of the genome and personalised medicine. Clin Med 2017;17:545–51. https://doi.org/10.7861/clinmedicine.17-6-545.

3. Harvey, A, Brand, A, Holgate, ST, Kristiansen, LV, Lehrach, H, Palotie, A, et al.. The future of technologies for personalised medicine. N Biotech 2012;29:625–33. https://doi.org/10.1016/j.nbt.2012.03.009.

4. Horgan, D. From here to 2025: personalised medicine and healthcare for an immediate future. J Cancer Policy 2018;16:6–21. https://doi.org/10.1016/j.jcpo.2017.12.008.

5. Kandeel, M. Oncogenic viruses-encoded microRNAs and their role in the progression of cancer: emerging targets for antiviral and anticancer therapies. Pharmaceuticals 2023;16:485. https://doi.org/10.3390/ph16040485.